New Alzheimer's Test Approved by FDA—What to Know

Industry Updates
Written By Kaleidoscope Management Group
 
 
 

The FDA has approved the first blood test to assist in diagnosing Alzheimer's.

While a definitive stand-alone test for Alzheimer’s diagnosis doesn't yet exist, this FDA milestone represents a significant stride towards quicker and earlier diagnosis, crucial now that treatments for early-stage Alzheimer's are available.

 
Kaleidoscope Management Group
Previous

Elevated α-Synuclein Aggregate Levels in the Urine of Patients with Isolated REM Sleep Behavior Disorder and Parkinson's Disease
Next

Ultraprocessed Foods Linked to Early Symptoms of Parkinson’s